Results 111 to 120 of about 8,329 (233)

AcuD Gene Knockout Attenuates the Virulence of Talaromyces marneffei in a Zebrafish Model

Mycobiology, 2019
Talaromyces marneffei is the only dimorphic species in its genus and causes a fatal systemic mycosis named talaromycosis. Our previous study indicated that knockdown of AcuD gene (encodes isocitrate lyase of glyoxylate bypass) of T.
Jiao Feng, Zhiwen Chen, Liya He, Xing Xiao, Chunmei Chen, Jieming Chu, Eleftherios Mylonakis, Liyan Xi   +7 more
doaj   +1 more source

Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals Pneumocystis and Beyond [PDF]

, 2017
Many fungi cause pulmonary disease in HIV-infected patients. Major pathogens include Pneumocystis jirovecii, Cryptococcus neoformans, Aspergillus species, Histoplasma capsulatum, Coccidioides species, Blastomyces dermatitidis, Paracoccidioides ...
Huang, L, Miller, RF, Wang, RJ
core  

Efficient hydrolysis of raw starch and ethanol fermentation: a novel raw starch-digesting glucoamylase from Penicillium oxalicum [PDF]

, 2016
Additional file 3: Figure S2. SDS-PAGE analysis of the recombinant rPoGA15A and native PoGA15A. Lane 1, protein molecular weight marker; lane 2, the purified recombinant rPoGA15A; lane 3, the native ...
Jia-Xun Feng, Qiang-Sheng Xu, Yu-Si Yan
core   +5 more sources

Small Interfering RNA Mediated Messenger RNA Knockdown in the Amphibian Pathogen Batrachochytrium dendrobatidis

Journal of Basic Microbiology, Volume 64, Issue 8, August 2024.
ABSTRACT RNA interference (RNAi) has not been tested in the pandemic amphibian pathogen, Batrachochytrium dendrobatidis, but developing this technology could be useful to elucidate virulence mechanisms, identify therapeutic targets, and may present a novel antifungal treatment option for chytridiomycosis.
Rebecca J. Webb, Alexandra A. Roberts, Catherine Rush, Lee F. Skerratt, Mark L. Tizard, Lee Berger   +5 more
wiley   +1 more source

Closing the Brief Case: Pneumonia Caused by Talaromyces marneffei [PDF]

Journal of Clinical Microbiology, 2019
1. T. marneffei infection occurs primarily in individuals who: Answer: a. T. marneffei infection is most common in HIV/AIDS patients who reside in or who have traveled to regions where the fungus is endemic, such as southern China, Taiwan, Hong Kong, and other parts of southeast Asia.
Lori, Bourassa, Avanthi, Doppalapudi, Susan M, Butler-Wu   +2 more
openaire   +2 more sources

Disseminated Infections with Talaromyces marneffei in Non-AIDS Patients Given Monoclonal Antibodies against CD20 and Kinase Inhibitors

Emerging Infectious Diseases, 2015
Infections with the fungus Talaromyces (formerly Penicillium) marneffei are rare in patients who do not have AIDS. We report disseminated T. marneffei infection in 4 hematology patients without AIDS who received targeted therapy with monoclonal ...
Jasper F.W. Chan, Thomas S.Y. Chan, Harinder Gill, Frank Y.F. Lam, Nigel J. Trendell-Smith, Siddharth Sridhar, Herman Tse, Susanna K.P. Lau, Ivan F.N. Hung, Patrick C.Y. Woo, Kwok-Yung Yuen   +10 more
doaj   +1 more source

Exosomes released from macrophages infected with Talaromyces marneffei activate the innate immune responses and decrease the replication

Immunity, Inflammation and Disease, 2023
Introduction Recent studies have demonstrated that exosomes play roles in pathogenesis and in the treatment of various diseases. We explored the influence of exosomes released from Talaromyces marneffei (T.
Guangquan Ji, Shan Feng, Hong Ren, Wenhao Chen, Renqiong Chen   +4 more
doaj   +1 more source

Генетико-таксономический анализ микромицетов на основе данных геномного секвенирования [PDF]

, 2015
Целью данной работы явился сравнительный генетико-таксономический анализ нового фитопатогенного гриба Phomasp.1 с различными представителями отдела Ascomycota на основе использования данных геномного ...
Баранов, Олег Юрьевич, Пантелеев, Станислав Викторович, Рубель, Илья Эдуардович   +2 more
core  

Talaromyces marneffei and Burkholderia cepacia Co-Infection in a HIV-Uninfected Patient with Anti-Interferon-γ Autoantibodies

Infection and Drug Resistance, 2021
Wen Zeng,1,2 Ye Qiu,1,2 Mengxin Tang,1,2 Hui Zhang,2 Mianluan Pan,1 Shudan Tang,2 Jianquan Zhang1 1Department of Respiratory and Critical Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518000, People’s ...
Zeng W, Qiu Y, Tang M, Zhang H, Pan M, Tang S, Zhang J   +6 more
doaj  

Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting? [PDF]

, 2019
Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring.
Kenny, Claire, Muldoon, Eavan G., Rae, Nikolas   +2 more
core   +2 more sources